Date Title Description PDF
25 Apr 2023 On business and financial situation ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE) Download
21 Feb 2023 On business and financial situation The Company releases the full year 2022 financial results presentation. Download
21 Feb 2023 On business and financial situation The Company releases the press release related to the full year 2022 financial results. Download
21 Feb 2023 On business and financial situation The company releases the Integrated Report for the year 2022 Download
21 Feb 2023 About Corporate Governance The Company informs about the agreements adopted by the Board of Directors Download

Pages

Date Title Description PDF
07 Oct 2021 Liquidity and counterparty agreements Download
04 Oct 2021 Liquidity and counterparty agreements Download
01 Sep 2021 On business and financial situation ROVI informs about the joint statement from Moderna and Takeda on the investigation of suspended lots of the vaccine Download
28 Jul 2021 On business and financial situation The company releases the press release related to first half 2021 financial results Download
28 Jul 2021 On business and financial situation ROVI releases the first half 2021 results presentation Download

Pages

Date Title Description PDF
08 Nov 2016 Información sobre resultados ROVI releases the presentation related to the nine-month period ended 30 September 2016 results Download
08 Nov 2016 Información sobre resultados (2) ROVI releases the press release related to the nine-month period ended 30 September 2016 results Download
08 Nov 2016 Otros sobre Gobierno Corporativo The Company informs about the agreement of the Board of Directors with regards to the appointment of the Accounts Auditor Download
04 Oct 2016 Contratos de liquidez y contrapartida Liquidity contract: transactions conducted in the third quarter of 2016 Download
01 Aug 2016 Acuerdos estratégicos con terceros ROVI announces the marketing agreement of Mysimba in Spain Download

Pages